We’re proud to participate in the Michael J. Fox Foundation’s 2019 Parkinson’s Disease Therapeutics Conference. This annual scientific conference is focused exclusively on Parkinson’s Disease drug development. Members of the Cohen Veterans Bioscience team will be presenting findings from our Inflammation Cross-Platform Comparison study.
The Parkinson’s Disease Therapeutics Conference is The Michael J. Fox Foundation’s annual scientific conference and the only one in the world focused exclusively on Parkinson’s disease drug development. The 13th Annual PD Therapeutics Conference will be held on October 15, 2019 at Convene Midtown East, New York City.
The PD Therapeutics Conference brings together 300 research and business development professionals from both academia and industry and showcases the most exciting and innovative research from MJFF’s research portfolio. Novel advances in basic and translational research from both academic and industry labs are highlighted through speaker presentations and a poster session. The event is a platform for field leaders to share new and unpublished results and for fostering new relationships and collaborations.